Can circulating M30 and M65 levels be beneficial markers in the diagnosis and management of patients with complete hydatidiform mole?
Crossref DOI link: https://doi.org/10.1007/s00508-015-0735-5
Published Online: 2015-04-14
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Incebiyik, Adnan
Vural, Mehmet
Camuzcuoglu, Hakan
Taskin, Abdullah
Camuzcuoglu, Aysun
Hilali, Nese Gul
Aksoy, Nurten
Text and Data Mining valid from 2015-04-14